During 3Q15, $PFE's diluted weighted-average shares outstanding declined by 160MM shares compared to the prior-year quarter due to Pfizer's share repurchase program, including the impact of the $5Bil accelerated share repurchase agreement executed in Feb. 2015 and completed in July 2015.
Healthcare and security technology company $ALOG posted
higher 1Q17 results, helped by higher revenue and lower cost of sales in
Engineering segment. For the quarter, net income rose 83.33% to $2.53MM or
$0.20 per share from $1.38MM or $0.11 per share a year ago. Revenue rose 5.36%
$121.12MM. Excluding items, $ALOG earned $0.43 per share.
$TSN said Jeffrey Schomburger, Global Sales Officer for $PG, has been selected as a new independent director on the $TSN board, effective Dec. 5, 2016. The board is expanding from 10 to 11 members, and Schomburger will be one of 8 independent directors.